Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle Cells

Open Access

Peer-reviewed

Research Article

John Gatfield ,

* E-mail: john.gatfield@actelion.com

Affiliation Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
⨯
Celia Mueller Grandjean,

Affiliation Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
⨯
Thomas Sasse,

Affiliation Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
⨯
Martine Clozel,

Affiliation Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
⨯
Oliver Nayler

Affiliation Actelion Pharmaceuticals Ltd., Allschwil, Switzerland
⨯

Reader Comments (7)

Calcium signaling
Is the Subject Area "Calcium signaling" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Computer software
Is the Subject Area "Computer software" applicable to this article?

Thanks for your feedback.
G protein coupled receptors
Is the Subject Area "G protein coupled receptors" applicable to this article?

Thanks for your feedback.
Intracellular receptors
Is the Subject Area "Intracellular receptors" applicable to this article?

Thanks for your feedback.
Pulmonary arteries
Is the Subject Area "Pulmonary arteries" applicable to this article?

Thanks for your feedback.
Second messenger system
Is the Subject Area "Second messenger system" applicable to this article?

Thanks for your feedback.
Smooth muscle cells
Is the Subject Area "Smooth muscle cells" applicable to this article?

Thanks for your feedback.